Advanced in Iridocorneal Endothelial Syndrome

Dr. Natalie A. Afshari

Ophthalmology
Regents Of The University Of California
200 W Arbor Dr, 
San Diego, CA 
Advanced in Iridocorneal Endothelial Syndrome
Regents Of The University Of California
200 W Arbor Dr, 
San Diego, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Natalie Afshari is an Ophthalmologist in San Diego, California. Dr. Afshari is rated as an Advanced provider by MediFind in the treatment of Iridocorneal Endothelial Syndrome. Her top areas of expertise are Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, Cataract, Cataract Removal, and Corneal Transplant.

Her clinical research consists of co-authoring 128 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Ophthalmology
Licenses
Ophthalmology in CA
Hospital Affiliations
Uc San Diego Health Hillcrest - Hillcrest Med Ctr
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

REGENTS OF THE UNIVERSITY OF CALIFORNIA
200 W Arbor Dr, San Diego, CA 92103

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 1/2 Study to Determine Safety and Efficacy of Transplantation With Autologous Human CD34+ Hematopoietic Stem Cells (HSC) From Mobilized Peripheral Blood Stem Cells (PBSC) of Patients With Cystinosis Modified by Ex Vivo Transduction Using pCCL-CTNS or pCDY.EFS.CTNS.T260I Lentiviral Vector and Will Include Transduction Enhancer When Required During Manufacturing
A Phase 1/2 Study to Determine Safety and Efficacy of Transplantation With Autologous Human CD34+ Hematopoietic Stem Cells (HSC) From Mobilized Peripheral Blood Stem Cells (PBSC) of Patients With Cystinosis Modified by Ex Vivo Transduction Using pCCL-CTNS or pCDY.EFS.CTNS.T260I Lentiviral Vector and Will Include Transduction Enhancer When Required During Manufacturing
Enrollment Status: Completed
Publish Date: March 20, 2025
Intervention Type: Genetic
Study Phase: Phase 1/Phase 2
A Phase I/II Prospective, Randomized, Multicenter, Double-Masked, Vehicle-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Corneal Collagen Cross-Linking of Keratoprosthesis Carrier Tissue in High-Risk Keratoprosthesis Implantation
A Phase I/II Prospective, Randomized, Multicenter, Double-Masked, Vehicle-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Corneal Collagen Cross-Linking of Keratoprosthesis Carrier Tissue in High-Risk Keratoprosthesis Implantation
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Drug, Device
Study Phase: Phase 1/Phase 2
An 8-week Phase II, Multicenter, Randomized, Double-masked, Vehicle Controlled Parallel Group Study With a 24 or 32 Week Follow-up to Evaluate the Efficacy of rhNGF 20 µg/ml vs Vehicle in Patients With Stage 2 and 3 Neurotrophic Keratitis
An 8-week Phase II, Multicenter, Randomized, Double-masked, Vehicle Controlled Parallel Group Study With a 24 or 32 Week Follow-up to Evaluate the Efficacy of rhNGF 20 µg/ml vs Vehicle in Patients With Stage 2 and 3 Neurotrophic Keratitis
Enrollment Status: Completed
Publish Date: December 08, 2022
Intervention Type: Other, Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

128 Total Publications

Effect of Haptic Design, Passing Direction, and Inter-Flange Distance on the Position of the Intraocular Lens during 4-Flanged Intrascleral Fixation.
Effect of Haptic Design, Passing Direction, and Inter-Flange Distance on the Position of the Intraocular Lens during 4-Flanged Intrascleral Fixation.
Journal: Current eye research
Published: May 12, 2025
Similar Doctors
Experienced in Iridocorneal Endothelial Syndrome
Dr. Sarjan H. Patel
Ophthalmology
Experienced in Iridocorneal Endothelial Syndrome
Dr. Sarjan H. Patel
Ophthalmology

Emergency And Acute Care Medical Corporation

7901 Frost St, 
San Diego, CA 
 (3.2 miles away)
858-939-3400
Languages Spoken:
English, Hindi, Japanese, Spanish
See accepted insurances
Accepting New Patients

Sarjan Patel is an Ophthalmologist in San Diego, California. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Iridocorneal Endothelial Syndrome. His top areas of expertise are Cataract, Dry Eye Syndrome, Pinguecula, and Glaucoma. Dr. Patel is currently accepting new patients.

Experienced in Iridocorneal Endothelial Syndrome
Dr. Eric J. Linebarger
Ophthalmology
Experienced in Iridocorneal Endothelial Syndrome
Dr. Eric J. Linebarger
Ophthalmology

Sharp Rees-Stealy Medical Group Inc

3075 Health Ctr Dr, Suite 401, 
San Diego, CA 
 (3.1 miles away)
858-499-2600
Languages Spoken:
English
See accepted insurances

Eric Linebarger is an Ophthalmologist in San Diego, California. Dr. Linebarger is rated as an Advanced provider by MediFind in the treatment of Iridocorneal Endothelial Syndrome. His top areas of expertise are Cataract, Interstitial Keratitis, Sjogren Syndrome, and Pterygium.

Experienced in Iridocorneal Endothelial Syndrome
Dr. John G. Tew
Ophthalmology
Experienced in Iridocorneal Endothelial Syndrome
Dr. John G. Tew
Ophthalmology

Inland Eye Specialists A Medical Corp

25395 Hancock Ave, Suite 100, 
Murrieta, CA 
 (55.6 miles away)
951-696-5388
Languages Spoken:
English, Portuguese
See accepted insurances
Accepting New Patients

John Tew is an Ophthalmologist in Murrieta, California. Dr. Tew is rated as a Distinguished provider by MediFind in the treatment of Iridocorneal Endothelial Syndrome. His top areas of expertise are Cataract, Glaucoma, Pterygium, and Interstitial Keratitis. Dr. Tew is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Afshari's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile